Neurosense Therapeutics Correlations

NRSN Stock

USD 0.92 0.07 7.07%

The current 90-days correlation between Neurosense Therapeutics and Kiora Pharmaceuticals is -0.06 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurosense Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurosense Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Neurosense Therapeutics Correlation With Market

Modest diversification

The correlation between Neurosense Therapeutics and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.

Moving together with Neurosense Stock

0.73

VRDN

Viridian Therapeutics

Pair Corr

Moving against Neurosense Stock

0.75	DYN	Dyne Therapeutics	Pair Corr
0.73	VRAX	Virax Biolabs Group	Pair Corr
0.69	BDRX	Biodexa Pharmaceticals Upward Rally	Pair Corr
0.61	KALV	Kalvista Pharmaceuticals	Pair Corr
0.57	REVB	Revelation Biosciences	Pair Corr
0.4	LGVN	Longeveron LLC	Pair Corr
0.37	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.35	VRPX	Virpax Pharmaceuticals	Pair Corr
0.33	CYTK	Cytokinetics	Pair Corr

Related Correlations Analysis

	KPRX	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX
KPRX		0.41	0.25	0.14	0.33	-0.33	0.21	KPRX
ZVSA	0.41		0.68	-0.08	0.34	-0.19	-0.05	ZVSA
SONN	0.25	0.68		0.03	0.55	-0.22	-0.02	SONN
ZURA	0.14	-0.08	0.03		0.25	0.54	0.29	ZURA
PHIO	0.33	0.34	0.55	0.25		0.14	-0.14	PHIO
RNAZ	-0.33	-0.19	-0.22	0.54	0.14		-0.03	RNAZ
QNRX	0.21	-0.05	-0.02	0.29	-0.14	-0.03		QNRX
	KPRX	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SONN	+ 0.68	ZVSA
PHIO	+ 0.55	SONN
RNAZ	+ 0.54	ZURA
ZVSA	+ 0.41	KPRX
PHIO	+ 0.34	ZVSA
PHIO	+ 0.33	KPRX

High negative correlations

RNAZ	- 0.33	KPRX
RNAZ	- 0.22	SONN
RNAZ	- 0.19	ZVSA
QNRX	- 0.14	PHIO
ZURA	- 0.08	ZVSA
QNRX	- 0.05	ZVSA

Risk-Adjusted Indicators

There is a big difference between Neurosense Stock performing well and Neurosense Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurosense Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KPRX	2.77	(0.29)	0.00	(0.26)	0.00	0.00	5.95	(4.97)	16.59
ZVSA	4.67	(0.99)	0.00	0.60	0.00	0.00	9.17	(10.36)	78.93
SONN	4.76	(0.77)	0.00	2.19	0.00	0.00	12.31	(9.79)	37.58
ZURA	3.78	(0.36)	0.00	(0.09)	0.00	0.00	7.95	(7.94)	30.69
PHIO	4.53	(0.30)	0.00	(0.18)	0.00	0.00	11.78	(10.38)	36.22
RNAZ	7.63	1.05	0.10	(0.44)	6.52	(11.84)	22.00	(11.43)	68.80
QNRX	6.21	0.47	0.07	0.37	6.73	(8.82)	17.65	(9.68)	74.46

Neurosense Therapeutics Corporate Management

Sharon Vered	Global CMC	Profile
Diana Shtossel	Head Affairs	Profile
Or Eisenberg	Chief Officer	Profile
Nedira SalzmanFrenkel	Global Devel	Profile
Yael Barak	Head Compliance	Profile
Alon BenNoon	CEO CoFounder	Profile
Hagit Binder	VP Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC